In summary, these results highlight the cytoprotective effect of autophagy on SGC7901 cells treated with T-DM1, suggesting that combining T-DM1 with autophagy inhibitors could enhance treatment efficacy in HER2-low gastric cancer. This evidence concerns the gene ERBB2 and gastric cancer.